• Sentimag Gen Ad x
  • US KEY Keytruda ADT HCP Update Patient Candidate Banner Ads MT Branded Static x
  • Surgical Oncology Insight Banner Ad x

ADVERTISEMENT

Global Header
MENU
SSO logo reverse
Facebook-f Twitter Youtube
Society of Surgical Oncology > Annals of Surgical Oncology > ASO Research Letters – Ongoing Clinical Research > ASO Research Letters – Hepatobiliary Cancer​

ASO Research Letters – Hepatobiliary Cancer​

Below find articles on hepatobiliary cancer from the Annals of Surgical Oncology’s, Research Letters Series-Ongoing Clinical Research. The visual abstracts can be enlarged by clicking on them.

The Role of Liver Resection for Patients with Liver and Unresectable Lung Colorectal Metastases (LUNA)

The Role of Liver Resection for Patients with Liver and Unresectable Lung Colorectal Metastases

A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA1, BRCA2 or PALB2 Mutation (The APOLLO Trial)

A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA BRCA or PALB Mutation

The WASH (Water or Saline at High Volumes) Trial: A Randomized Trial to Assess the Survival Impact of Extensive Peritoneal Lavage Using Distilled Water or Saline at High Volumes After Pancreatic Resection for Pancreatic Ductal Adenocarcinoma

The WASH Trial

Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) as a Bridge to Transplant in Unresectable Hepatocellular Carcinoma

Stereotactic Body Radiation Therapy

Perioperative Versus Adjuvant Chemotherapy in the Management of Incidentally Found Gallbladder Cancer (OPT-IN)

Perioperative Versus Adjuvant Chemotherapy in the Management of Incidentally Found Gallbladder Cancer

Treatment of Hepatocellular Carcinoma with Neoadjuvant Nivolumab Alone Versus in Combination with a CCR2/5 Inhibitor or an Anti-IL-8 Antibody

Treatment of Hepatocellular Carcinoma with Neoadjuvant Nivolumab Alone

Hepatic Artery Infusion Pump (HAIP) Therapy Versus Chemotherapy in the First-Line Setting for Patients with Unresectable Intrahepatic Cholangiocarcinoma

Hepatic Artery Infusion Pump Therapy Versus Chemotherapy

Neoadjuvant Chemotherapy Plus Living Donor Transplantation (LDLT) for Non-Resectable Liver Metastases from Colorectal Cancer (CRC)

Neoadjuvant Chemotherapy Plus Living Donor Transplantation
Navigate

Society of Surgical Oncology

9525 West Bryn Mawr Avenue, Suite 870
Rosemont, IL 60018 / Phone: 847-427-1400

© Society of Surgical Oncology. 2010-2023.

Scroll to Top
Facebook-f Twitter Youtube